Amgen (AMGN)

Purchases of Investments

$0.00

TTM · Period ending: · USD

AMGN logo

AMGN Purchases of Investments

Latest reported$0.00
AMGN TTM Purchases of Investments (-$74.40M → $0.00)
High-resolution chart · PNG

AMGN purchases of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen Purchases of Investments — Trailing twelve months (TTM) (USD)
Period endingPurchases of Investments (USD)
0
0
0
0
0
0
0
26,989,000,000
26,988,000,000
26,988,000,000
26,988,000,000
-225,000,000
-611,000,000
-2,587,000,000
-2,587,000,000
-2,362,000,000
-2,876,000,000
-1,303,000,000
-8,900,000,000
-12,049,000,000
-14,248,000,000
-15,945,000,000
-8,477,000,000
-5,661,000,000
-4,373,000,000
-2,625,000,000
-9,394,000,000
-15,186,000,000
-19,258,000,000
-22,907,000,000
-18,741,000,000
-19,563,000,000
-21,096,000,000
-29,262,000,000
-33,607,000,000
-32,073,000,000
-32,369,000,000
-26,576,000,000
-28,094,000,000
-28,867,000,000
-27,416,000,000
-27,641,000,000
-25,977,000,000
-24,839,000,000
-23,815,000,000
-29,925,000,000
-25,878,000,000
-24,918,000,000
-26,784,000,000
-17,885,000,000
-21,965,000,000
-25,255,000,000
-24,780,000,000
-27,072,000,000
-26,241,000,000
-21,566,000,000
-20,211,000,000
-20,113,000,000
-21,183,000,000
-21,463,000,000
-20,202,000,000
-18,645,000,000
-14,602,000,000
-13,149,000,000
-12,542,000,000
-11,998,000,000
-12,418,000,000
-13,440,000,000
-14,406,000,000
-12,457,000,000
-10,345,000,000
-9,137,000,000
-6,847,000,000
-5,856,000,000
-5,579,000,000
-5,641,000,000
-5,994,000,000
-6,096,000,000
-5,386,000,000
18,668,000,000
12,971,000,000
2,331,000,000
-9,597,000,000
-49,324,000,000
-42,515,400,000
-31,758,100,000
-21,488,000,000
-6,367,400,000
-5,997,100,000
-7,287,000,000
-5,320,300,000
-3,962,800,000
-4,503,800,000
-2,695,500,000
-2,952,800,000
-2,569,900,000
-1,200,100,000
-1,218,700,000
-918,200,000
-980,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.